These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 17267839)

  • 1. Nuchal translucency and the risk of congenital heart disease.
    Simpson LL; Malone FD; Bianchi DW; Ball RH; Nyberg DA; Comstock CH; Saade G; Eddleman K; Gross SJ; Dugoff L; Craigo SD; Timor-Tritsch IE; Carr SR; Wolfe HM; Tripp T; D'Alton ME
    Obstet Gynecol; 2007 Feb; 109(2 Pt 1):376-83. PubMed ID: 17267839
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The role of fetal nuchal translucency (NT) and ductus venosus blood flow (DV) in the detection of congenital heart defects].
    Baś-Budecka E; Perenc M; Sieroszewski P
    Ginekol Pol; 2010 Apr; 81(4):272-6. PubMed ID: 20476599
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nuchal translucency and cystic hygroma colli in screening for fetal major congenital heart defects in a series of 12,910 euploid pregnancies.
    Sananes N; Guigue V; Kohler M; Bouffet N; Cancellier M; Hornecker F; Hunsinger MC; Kohler A; Mager C; Neumann M; Schmerber E; Tanghe M; Nisand I; Favre R
    Ultrasound Obstet Gynecol; 2010 Mar; 35(3):273-9. PubMed ID: 20069678
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated first-trimester nuchal translucency increases the risk of congenital heart defects.
    Bahado-Singh RO; Wapner R; Thom E; Zachary J; Platt L; Mahoney MJ; Johnson A; Silver RK; Pergament E; Filkins K; Hogge WA; Wilson RD; Jackson LG;
    Am J Obstet Gynecol; 2005 May; 192(5):1357-61. PubMed ID: 15902108
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nuchal translucency measurement and congenital heart defects: modest association in low-risk pregnancies.
    Müller MA; Clur SA; Timmerman E; Bilardo CM
    Prenat Diagn; 2007 Feb; 27(2):164-9. PubMed ID: 17238215
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reexamining the optimal nuchal translucency cutoff for diagnostic testing in the cell-free DNA and microarray era: results from the Victorian Perinatal Record Linkage study.
    Hui L; Pynaker C; Bonacquisto L; Lindquist A; Poulton A; Kluckow E; Hutchinson B; Norris F; Pertile MD; Gugasyan L; Kulkarni A; Harraway J; Howden A; McCoy R; da Silva Costa F; Menezes M; Palma-Dias R; Nisbet D; Martin N; Bethune M; Poulakis Z; Halliday J
    Am J Obstet Gynecol; 2021 Nov; 225(5):527.e1-527.e12. PubMed ID: 33957116
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Abnormal first-trimester ductus venosus blood flow: a marker of cardiac defects in fetuses with normal karyotype and nuchal translucency.
    Martínez JM; Comas M; Borrell A; Bennasar M; Gómez O; Puerto B; Gratacós E
    Ultrasound Obstet Gynecol; 2010 Mar; 35(3):267-72. PubMed ID: 20052662
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fetal cardiac defects and increased nuchal translucency thickness: a prospective study.
    McAuliffe FM; Hornberger LK; Winsor S; Chitayat D; Chong K; Johnson JA
    Am J Obstet Gynecol; 2004 Oct; 191(4):1486-90. PubMed ID: 15507988
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of fetal nuchal translucency and ductus venosus Doppler at 11-14 weeks of gestation in the detection of major congenital heart defects.
    Favre R; Cherif Y; Kohler M; Kohler A; Hunsinger MC; Bouffet N; Tanghe M; Cancellier M; Nisand I
    Ultrasound Obstet Gynecol; 2003 Mar; 21(3):239-43. PubMed ID: 12666217
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nuchal translucency and fetal cardiac defects: a pooled analysis of major fetal echocardiography centers.
    Makrydimas G; Sotiriadis A; Huggon IC; Simpson J; Sharland G; Carvalho JS; Daubeney PE; Ioannidis JP
    Am J Obstet Gynecol; 2005 Jan; 192(1):89-95. PubMed ID: 15672008
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is the addition of the ductus venosus useful when screening for aneuploidy and congenital heart disease in fetuses with normal nuchal translucency?
    Prats P; Ferrer Q; Comas C; Rodríguez I
    Fetal Diagn Ther; 2012; 32(1-2):138-43. PubMed ID: 22585666
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Limitations of using first-trimester nuchal translucency measurement in routine screening for major congenital heart defects.
    Mavrides E; Cobian-Sanchez F; Tekay A; Moscoso G; Campbell S; Thilaganathan B; Carvalho JS
    Ultrasound Obstet Gynecol; 2001 Feb; 17(2):106-10. PubMed ID: 11251916
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is measurement of nuchal translucency thickness a useful screening tool for heart defects? A study of 16,383 fetuses.
    Westin M; Saltvedt S; Bergman G; Almström H; Grunewald C; Valentin L
    Ultrasound Obstet Gynecol; 2006 Jun; 27(6):632-9. PubMed ID: 16715530
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Screening performance of first trimester nuchal translucency, ductus venosus blood flow and tricuspid regurgitation for cardiac defects].
    Geipel A; Gembruch U
    Z Geburtshilfe Neonatol; 2012 Aug; 216(4):157-61. PubMed ID: 22926815
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk of critical congenital heart defects by nuchal translucency norms.
    Jelliffe-Pawlowski LL; Norton ME; Shaw GM; Baer RJ; Flessel MC; Goldman S; Currier RJ
    Am J Obstet Gynecol; 2015 Apr; 212(4):518.e1-10. PubMed ID: 25448520
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The nuchal translucency and the fetal heart: a literature review.
    Clur SA; Ottenkamp J; Bilardo CM
    Prenat Diagn; 2009 Aug; 29(8):739-48. PubMed ID: 19399754
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence of major structural cardiac defects associated with increased nuchal translucency but normal karyotype.
    Ghi T; Huggon IC; Zosmer N; Nicolaides KH
    Ultrasound Obstet Gynecol; 2001 Dec; 18(6):610-4. PubMed ID: 11844199
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased nuchal translucency at 10-14 weeks of gestation as a marker for major cardiac defects.
    Hyett JA; Perdu M; Sharland GK; Snijders RS; Nicolaides KH
    Ultrasound Obstet Gynecol; 1997 Oct; 10(4):242-6. PubMed ID: 9383874
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nuchal Translucency and Congenital Heart Defects.
    Sofia-Gonçalves A; Guedes-Martins L
    Curr Cardiol Rev; 2024; 20(2):1-13. PubMed ID: 38275068
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Measurement of nuchal translucency for prenatal screening of congenital heart defects: a population-based evaluation.
    Jouannic JM; Thieulin AC; Bonnet D; Houyel L; Lelong N; Goffinet F; Khoshnood B
    Prenat Diagn; 2011 Dec; 31(13):1264-9. PubMed ID: 22028040
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.